mutations and complex kar yotype. It follows a linear evolution with the CLL clone through the recurrent acquisition of CDKN2ANot all individuals with CLL call for therapy. Despite all modern advancements, the iwCLL nonetheless suggests watchful observation for sufferers with asymptomatic illness.86 This advice relies on a minimum of two randomized